ISIN | LU1176840327 |
---|---|
Valorennummer | 26967218 |
Bloomberg Global ID | |
Fondsname | PROTEA - Sectoral Biotech Opportunities Fund PF USD |
Fondsanbieter |
Sectoral Asset Management Inc
1010 Sherbrooke St. West, Suite 1610 QC H3A 2R7 Montreal Canada Telefon: +1 514 849 8777 E-Mail: BusinessDevelopment@sectoral.com |
Fondsanbieter | Sectoral Asset Management Inc |
Vertreter in der Schweiz |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(en) | |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Ausgabekommission zugunsten der Fondsleitung und/oder des Vertriebsträgers (kann bei gleichem Fonds je nach Vertriebskanal unterschiedlich sein) |
Konditionen bei der Rücknahme | Rücknahmekommission zugunsten der Fondsleitung und/oder des Vertriebsträgers (kann bei gleichem Fonds je nach Vertriebskanal unterschiedlich sein) |
Investment-Strategie *** | This Sub-Fund aims to achieve capital growth in USD. While respecting the principle of risk diversification, the Sub-Fund’s assets are primarily invested in equities, equity-like transferable securities, participation certificates etc. issued by particularly innovative small, mid and large cap biotech companies worldwide which are active in the human medicine sector and depositary receipts, such as American Depositary Receipts (ADRs), Global Depositary Receipts (GDRs) and European Depositary Receipts (EDRs), referring to such securities. While no geographical restrictions apply re. specific countries or regions, the industry and therefore the Sub-Fund’s investments are centered in North America and Western Europe. |
Besonderheiten |
Aktueller Preis * | 9.18 USD | 06.09.2024 |
---|---|---|
Vorheriger Preis * | 9.29 USD | 05.09.2024 |
52 Wochen Hoch * | 9.50 USD | 21.08.2024 |
52 Wochen Tief * | 7.52 USD | 27.10.2023 |
NAV * | 9.18 USD | 06.09.2024 |
Ausgabepreis * | 9.18 USD | 06.09.2024 |
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 28'135'075 | |
Anteilsklassevermögen *** | 1'983'272 | |
Trading Information SIX |
YTD-Performance | +3.15% |
29.12.2023 - 06.09.2024
29.12.2023 06.09.2024 |
---|---|---|
YTD-Performance (in CHF) | +3.29% |
29.12.2023 - 06.09.2024
29.12.2023 06.09.2024 |
1 Monat | +2.57% |
06.08.2024 - 06.09.2024
06.08.2024 06.09.2024 |
3 Monate | +4.56% |
06.06.2024 - 06.09.2024
06.06.2024 06.09.2024 |
6 Monate | +3.96% |
06.03.2024 - 06.09.2024
06.03.2024 06.09.2024 |
1 Jahr | +8.77% |
06.09.2023 - 06.09.2024
06.09.2023 06.09.2024 |
2 Jahre | +17.69% |
06.09.2022 - 06.09.2024
06.09.2022 06.09.2024 |
3 Jahre | -21.40% |
07.09.2021 - 06.09.2024
07.09.2021 06.09.2024 |
5 Jahre | +23.06% |
06.09.2019 - 06.09.2024
06.09.2019 06.09.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Amgen Inc | 8.84% | |
---|---|---|
Vertex Pharmaceuticals Inc | 8.52% | |
Regeneron Pharmaceuticals Inc | 7.63% | |
Gilead Sciences Inc | 7.54% | |
Biogen Inc | 4.38% | |
AstraZeneca PLC ADR | 4.00% | |
Moderna Inc | 3.57% | |
Alnylam Pharmaceuticals Inc | 3.23% | |
Biomarin Pharmaceutical Inc | 2.73% | |
Illumina Inc | 2.10% | |
Letzte Daten-Aktualisierung | 31.12.2023 |
TER | 2.33% |
---|---|
Datum TER | 30.06.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 2.10% |
Ongoing Charges *** | 2.32% |
SRRI ***
|
|
Datum SRRI *** | 31.08.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |